Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 11—November 2003
Dispatch

Flow Cytometry and T-Cell Response Monitoring after Smallpox Vaccination

Fabrizio Poccia*Comments to Author , Cristiana Gioia*, Carla Montesano*, Federico Martini*, Douglas Horejsh*, Concetta Castilletti*, Leopoldo Paolo Pucillo*, Maria Rosaria Capobianchi*, and Giuseppe Ippolito*
Author affiliations: *National Institute for Infectious Diseases “Lazzaro Spallanzani,” Rome, Italy

Main Article

Figure

Flow cytometric analysis of T-cell responses to smallpox antigens after recent smallpox vaccination and in long-term vaccinated or not vaccinated persons. Interferon (IFN)-γ synthesis by T cells after an in vitro stimulation with vaccinia antigens was analyzed in eight healthy donors selected as recently vaccinated, long-term vaccinated, and not vaccinated persons. A representative experiment is reported in this figure. Panels A and D refer to an unvaccinated healthy donor (25-year-old white man

Figure. Flow cytometric analysis of T-cell responses to smallpox antigens after recent smallpox vaccination and in long-term vaccinated or not vaccinated persons. Interferon (IFN)-γ synthesis by T cells after an in vitro stimulation with vaccinia antigens was analyzed in eight healthy donors selected as recently vaccinated, long-term vaccinated, and not vaccinated persons. A representative experiment is reported in this figure. Panels A and D refer to an unvaccinated healthy donor (25-year-old white man, current neutralizing antibodies absent). A long-term vaccinated healthy person is reported in panels B and E (29-year-old white man received two doses of vaccine virus by scarification >20 years ago, current vaccinia neutralizing antibody titer of 1:8). Results from a recently vaccinated person are shown in panels C and F (31-year-old white man, single dose of Dryvax vaccine virus [Wyeth Labs, Marietta, PA] by scarification, January, 2002, current vaccinia neutralizing antibody titer of 1:32). Serum was tested for standard neutralization assay. Briefly, 0.1 mL of serial twofold dilutions of each serum was mixed with an equal volume of vaccinia virus suspension containing ~100 TCID50. After incubation, virus-antibody mixtures, medium, and virus controls were inoculated onto monolayers of Vero cells seeded in 96-well plates. Concomitant retitration of virus suspension was run in parallel. After 48-h incubation at 37°C, the cytopathic effect was observed under light microscope, and the microplates were stained with crystal violet. For T-cell assays, peripheral blood mononuclear cells cultures were stimulated with vaccinia virus (panels A–C) or cytomegalovirus antigens (panels D–F), and intracellular IFN-γ synthesis was analyzed in CD3(+) T cells. Percentages in panel quadrants refer to total lymphocytes.

Main Article

Page created: January 21, 2011
Page updated: January 21, 2011
Page reviewed: January 21, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external